Tulane Ventures invests $125K in Beken Bio to advance early cancer detection technology and expand biotech innovation in New ...

Cancer will claim an estimated 618,000 lives in the U.S. in 2025, according to the American Cancer Society. Yet, despite advances in treatment, most of these deaths stem from cancers without guideline ...

Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI).

The American Cancer Society (ACS) released updated guidelines today for cervical cancer screening, reflecting advances in ...

Advances in surgery and a clearer understanding of early stage lung cancer are improving outcomes for many patients. Dr. Nabil Rizk, chief of thoracic surgery at Hackensack University Medical Center ...

Julio Aguirre-Ghiso, PhD, Rose C. Falkenstein Chair in Cancer Research, Professor of Cell Biology and Founding Director of the Cancer Dormancy Institute at Albert Einstein's Montefiore Einstein ...

Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and density-informed risk modeling December 3, ...

Exact Sciences’ Tomasz Beer, MD, explains how multi-cancer early detection is moving out of research and into practice—bringing new clinical and operational considerations with it ...

University Hospitals' latest facility at the Parma Medical Arts Center provides screening, diagnosis, treatment and ...

Together, American Cancer Society and Guardant Health aim to remove barriers and increase cancer screening rates in communities that have historically limited access to preventive cancer care. In 2025 ...

For decades, lung cancer has been associated with stigma, anxiety, and loss. Advances in screening, therapeutics, and survivorship have created a new reality; lung cancer is treatable, survivable, and ...

Proceeds will accelerate ongoing FDA registrational study of company’s first blood test for colorectal cancer screening and advance product pipeline Freenome will leverage its unique platform that ...